Theme I: General principles of drug action Flashcards

1
Q

What does pharmacodynamics mean. What does it help determine

A
  • The effect of the drug on the body
  • How it interacts with the target and where in the body.
  • How it produces an action in the cell
  • Helps determine the appropriate doses for patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does pharmacokinetics mean. What does it help determine

A
  • What the body does to the drug
  • How it is absorbed, distributed, metabolised and excreted.
  • Helps determine the frequency / duration/ route of administration of drugs. To ensure the correct drug concentration in plasma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 factors that affect the ability of drugs to bind to their targets (BP01)

A
  • Shape
  • Charge distribution: determines the type/ strength of bond that will be created
  • Stereochemistry: how the 3D structures are orientated
  • Hydrophobicity (how easily it gets through lipid bilayer)
  • ionisation (pKa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 main chemical bonds and a brief description, in increasing strength

A
  • Van der Waals forces: Shifting electron density resulting in fleeting + & - charges. These transient areas attract to molecules of opposite charge.
  • Hydrogen bonds: Hydrogen bound to oxygen or nitrogen makes it more positively polarised, so are attracted to negatively polarised atoms like oxygen.
  • Ionic bonds: Atoms with excess electrons (- ions) and atoms with deficient electrons (+) are attracted.
  • Covalent bonds: Two bonding atoms sharing electrons.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is an agonist

A
  • A ligand that binds to a receptor to elicit a cellular response.
  • Enhances the action of endogenous chemicals.
  • 2 step process: creates an agonist-receptor complex then the receptor causes action within the cell.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an antagonist

A
  • Blocks the action of endogenous chemical messengers or agonists.
  • Similar structure to endogenous chemical but does not cause any biological response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 3 different binding sites on a receptor

A
  • Orthosteric/ active sites: the normal site where endogenous products bind
  • Allosteric site: different site to where endogenous products bind (modulates enzymatic activity)
  • Effector region: other regions of the receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does efficacy & potency mean. What factors affect potency

A
  • Efficacy is how how effective a drug is at activating a receptor. It refers to the maximum effect it can produce.(Full agonists have high efficacy)
  • Potency is how much drug is needed to produce an effect. High potency means low concentration needed to elicit a response.
  • Potency relies on affinity, efficacy, receptor density & efficiency of stimulus-response mechanisms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is equilibrium dissociation constant (Kd) of a drug. What does low Kd mean

A
  • It shows the affinity between a given receptor & drug.
  • used to compare affinity of different drugs on the same receptor.
  • Dissociation is low when affinity & potency is high: tighter ligand-receptor interaction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a full, partial & inverse agonist. Relate them to efficacy

A
  • Full agonists can produce the maximum response in a system, while only occupying a small percentage of receptors. High efficacy.
  • Partial agonists are unable to produce a maximum response even when occupying all receptors. Low efficacy.
  • Inverse agonists have higher affinity for the inactive receptor-effector complex than the active. Form a complex and inhibit the effects, exerting opposing effects. (Similar effect to competitive antagonist)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What’s the meaning of spare receptors

A
  • Not likely there will be linear relationship between receptor occupancy and effect, where Kd (dissociation) and EC50 are equal (ie. 50% occupation causing 50% effect)
  • Many receptors amplify the signal duration & intensity. So a maximum response can occur even with a small fraction of receptors occupied. Receptors left over that are not bound to
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What causes desensitisation of receptors (with regards to drugs)

A
  • Continued and repeated administration of drugs can reduce its effects (tachyphylaxis)
  • Due to conformational changes of receptors, depletion of mediators, altered drug mechanisms etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain the 3 classes of antagonist (chemical, physiological and pharmacological) Give examples

A

1- Chemical: deactivates an agonist by binding to it and the agonist can no longer act on a receptor. (protamine binds heparin)
2- Physiological: 2 agents with opposite effects cancel each other out. Have opposing effects (glucocorticoids and insulin)
-^These 2 are not receptor antagonists
3- Pharmacological: binds to a receptor and blocks the action of an agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do competitive antagonists work, is it reversible and what the agonist-response curve looks like. Give an example of a drug

A
  • Bind to the normal active site on a receptor, preventing agonist binding so blocking the response.
  • It is reversible, by increasing concentration of agonist because it will be able to outcompete it.
  • Causes parallel shift to the right, with same form
  • Cimetidine on the H2 receptor. Atropine on muscarine receptor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What the dose ratio tells us and the Schild plot.

A
  • Dose ratio compares the ability of antagonists to inhibit agonists. It is the factor of how much we need to increase the agonist concentration when put in the presence of an antagonist
  • EC50 of agonist + antagonist / EC50 of agonist

-Schild plot can be drawn to work out the concentration of competitive antagonist used to inhibit the agonist. It is when the linear line intersects the x axis. = the log Kb value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are non-competitive active site antagonists, are they reversible and what does the curve looks like (EC50 and Emax)

A
  • Bind to active sites of receptors with strong covalent bonds so difficult to dissociate even when increasing agonist concentration.
  • irreversible
  • Increased EC50 so more agonist is required, and Emax is reduced so will never get a maximum response.
  • Need to wait for the receptor to regenerate for it to be reversible.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is a allosteric site antagonist, and is it reversible or irreversible

A
  • Non-competitive
  • Bind to allosteric site which changes the shape of receptor, inhibiting the binding & action of agonists
  • Can be irreversible or reversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is a therapeutic window/ index of a drug. Why is a large window ideal

A
  • The range of which a drug causes therapeutic effect, before having a toxic effect.
  • Larger window is safer in general
  • Large window useful for treating diseases with varying severity and symptoms (eg. penicillin for pain) because different doses will be required, and you still want it causing an effect without being toxic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a graded and quantal dose-response relationship

A
  • Graded: Response of a particular individual and tissue to different drug concentrations.
  • Quantal: Percentage response in a population, against dose of agonist or antagonist. Dose required to produce an absolute effect. Determined in each member of the population.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanisms of a G protein coupled receptor

A
  • Neurotransmitter or hormone binds to the membrane-bound receptor.
  • This receptor changes shape and interacts with Gs protein (a single polypeptide chain consisting of alpha, beta and gamma subunits), which releases GDP and binds GTP.
  • Then there is a secondary messenger system
  • Alpha subunit of G protein dissociates and activates Adenyl cyclase, then forms cAMP, protein kinase A, activating calcium channels and then causes contraction.
  • Depending on the G protein this pathway can also be inhibited.

eg. opioid, adrenoreceptors, muscarinic ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mechanisms of ligand gated ion channels (give an example), and how this compares to voltage gated channels.

A
  • Ligand-gated channels are linked to receptors, unlike voltage-gated
  • Ligand-gated channel opens when ligand binds, changing the excitability of a cell, causes hyperpolarization/ depolarisation, and changes the likelihood of an action potential occurring.(eg. nicotinic acetylcholine receptor)
  • Eg. hyperpolarisation used for anaesthetics

-Voltage-gates requires a change in electrical potential across a membrane to cause channels to open/ close.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Mechanism of enzyme (kinase) linked receptors

A
  • Extracellular signal proteins (eg insulin) binds to extracellular domain.
  • This domain is connected to an intracellular domain (eg. tyrosine kinase) and is activated.
  • Tyrosine is autophosphorylated and then phosphorylates other proteins. Phosphate group is transferred between amino acids in different proteins.
  • Activation of multiple signalling pathways. Causing the biological effect of insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Nuclear receptors mechanism. Give an example of a hormone that acts on this receptor

A
  • Receptor present in cytosol or nucleus.
  • Lipid soluble hormone must diffuse across the membrane to bind to it.
  • Activated receptor moves to nucleus if not already.
  • The drug-receptor complex binds to chromatin and unwinds it, initiating gene transcription. Switch genes on or off
  • mRNA is then translated into specific proteins that result in a specific biological response.
  • Takes a while for response to occur because drug needs to get through membrane
  • Eg. steroid hormone (glucocorticoids)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Stages of pharmacokineteics (absorption etc.)

A
  • Absorption: drug transferred from site of administration, crosses membranes and into plasma/ systemic circulation
  • Distribution: once absorbed into blood it is distributed into tissues (usually passive diffusion of the uni-ionised form)
  • Metabolism & excretion: once the drug has been established and reached equilibrium between tissue & plasma it is broken down (inactivated and made water soluble) and eliminated in urine or faeces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

3 ways drug can cross lipid membrane and be absorbed

A

1-Passive diffusion: down concentration gradient through the lipid bilayer
2-Diffusion through aqueous channel: for aqueous drugs
3-Carrier-mediated active transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Advantages and disadvantages of oral administration and the different absorption sites when administered this way

A

-Oral is easy, non-invasive, done at home. BUT can be unreliable if GI absorption isn’t effective due to vomitting or diarrhoea.

  • Stomach absorption: not common site due to low pH changing ionising state of drug. Only some weak acids can work here.
  • small intestines: weak acid & bases well absorbed. Large surface area, highly vascular and very permeable. Enterocytes of epithelium contain enzymes & transporters that metabolise drugs. However unreliable if patient is vomitting or has diarrhoea. The drug could bind to food so cannot be absorbed. The drug must cross several barriers. Potential first pass metabolism
  • Sublingual: Rapid response as it utilises venous drainage from the mouth straight to the superior vena cava so avoids gut & hepatoportal circulation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Factors that affect GI absorption

A
  • very high or very low gastric motility and emptying causes low absorption (vomitting, diarrhoea)
  • low gut pH makes strong acids and bases ineffective. Low pH means alkaline drugs are in ionised state so not lipid soluble so poorly absorbed.
  • Drug can bind to food or bile which decreases absorption
  • Particle size and formulation of drug affects absorption.
  • Some drugs can either be slow releasing or fast acting.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is drug bioavailability (F) What causes low F. What are the limitations involved in the data that F shows

A
  • proportion of administered drug dose which enters the systemic circulation
  • First-pass metabolism (eg. being metabolised in the intestine or liver before reaching the systemic circulation) causes drug to be lost, so F is lower.
  • IV has F=1 because it enters straight into the blood plasma
  • Doesn’t take into consideration rate of absorption, or variations in individuals’ enzyme activity, gut pH and intestine motility.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Meanings of unionised and ionised drug and how this affects drugs crossing membrane

A
  • Drugs can be in an un-ionised/non-polar/neutral, or ionised state depending on the environmental pH
  • Acid in acidic environment is neutral, acid in alkaline is ionised.
  • Neutral substances are lipid soluble so can easily move across cell membranes and therefore have high absorption.
  • Ionized substances have lipid solubility and low absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How pKa and pH can be used to work out ionisation and absorption of drugs. What if pKa is 2 and pH is 2

A
  • pKa is a measure of strength of an an acid or base drug. It is the disassociation constant (ACID = ACID + H)
  • pH minus the pKa gives level of ionisation. It tells you the amount of drug that is unionised and neutral.
  • if a drug of pKa 2 is put in a solution with pH 2 then 50/50 ionised and neutral.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How the concentration of a drug in plasma against time differs between drugs taken orally or by IV. What Cmax and Tmax is on the curve

A

Cmax: maximum concentration of the drug in plasma after administration
Tmax: time at which Cmax is reached

  • IV drugs enter straight into blood plasma so the concentration curve starts at Cmax and then slowly decreases over time. Tmax very low.
  • Drug taken orally takes a while to reach Cmax while it is being absorbed, so longer Tmax
  • Cmax will be smaller than for IV.
  • Once the drug is established and achieves equilibrium between tissue and plasma (Cmax), the curve decreases as the body starts metabolising and excreting it.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Factors that affect the rate, and the extent of drug distribution into tissues.

A
  • Rate = Membrane permeability (ability to cross membranes)
  • Blood perfusion (flow to tissues)
  • Extent = Lipid solubility of drug (ionisation state)
  • Extent of plasma protein binding
  • Tissue binding
33
Q

How plasma protein binding affects distribution of drug into tissues. Give an example of protein. What factors affect binding. Can binding be reversed.

A
  • Proteins in the plasma (albumin) can bind drugs which inhibits their distribution so slows drug action and therapeutic effects. Drug stays in the systemic circulation.
  • Amount of drug bound depends on conc of free drug, affinity for the binding sites and the conc of protein.
  • Reversible by reducing protein or increasing drug dose
34
Q

What volume of distribution (Vd) of a drug measures. How it can be used to calculate drug dose. What low and high Vd means

A
  • Measures the extent of drug distribution into tissues.
  • Relationship between the total amount of drug in the body compared to in the plasma.
  • Vd = original dose/ plasma concentration
  • Vd is high if drugs accumulate outside plasma
  • Low Vd indicates it is confined to the plasma and not distributed very well into tissues.
  • Plasma concentration of a drug dictates the ability of a drug to reach its target organ in an effect concentration, therefore defines dose.
35
Q

Why drugs need to be metabolised before being excreted. What are the 2 phases, enzymes involved etc.

A

1-Most drugs are lipophilic (to get through membranes for absorption) but they need to be made water soluble (hydrophilic) in order to be excreted, otherwise it would continue being reabsorbed.
2- And it needs to be deactivated.

  • Metabolism involves Phase 1 and Phase 2:
  • Phase 1= adds a functional group to decrease lipid solubility (by oxidation, hydrolysis or reduction). This increases the drug’s activity so may become toxic. CYP P450 are a family of enzymes involved in adding a functional group.

-Phase 2= Conjugation. Adds hydrophilic component (eg. glucuronyl group via glucuronidation) to further decrease lipid solubility, and also to make it inactive and not toxic. This conjugate can then be excreted in urine or bile.

36
Q

What is first-pass metabolism and where does it occur. What is Enterohepatic recirculation (EHR). Examples of drugs that do this

A

-First-pass metabolism occurs in the intestine or liver (maybe in portal vein too) before reaching the systemic circulation so it reduces bioavailability.

  • Some drugs can undergo EHR. Drugs can be eliminated in the bile, stored in the gallbladder then re-released into the intestine/ duodenum. There is a secondary increase in plasma concentration so see an extra peak on a graph.
  • Eg. morphine, oral contraceptives, lorazepam
37
Q

How does the metabolism of alcohol differ to other drugs. Main steps in its metabolism

A

1-Alcohol is metabolised at a constant rate (zero order) - it doesn’t depend on the concentration in the body, unlike most drugs that increase rate when there is a higher conc of it in the body (first order) = has saturable metabolism
2-It uses different enzymes in the body to metabolise it (not just CYPs)
3- Metabolised almost entirely by the liver

  • Ethanol converted to acetaldehyde by alcohol dehydrogenase.
  • If there is chronic administration it will be converted by CYP2E1.
  • Acetylaldehyde converted to acetic acid by aldehyde dehydrogenase.
38
Q

How paracetamol is metabolised. Mention the phase 1 and 2 steps. What happens if there is an overdose.

A
  • Metabolized mainly by conjugation (Phase 2) which will inactivate it.
  • Small proportion is metabolised by CYP450 (Phase 1) to a toxic metabolite called NAPQI. This will then be detoxified by conjugation, into mercapturic acid.

-If overdose, conjugation pathways become saturated so more paracetamol is metabolised via Phase 1 which causes a build up of toxic NAPQI. This can cause hepatic necrosis.

39
Q

Effects of drug-drug interactions: metabolism inhibition & induction. Clinical relevance

A
  • Exogenous chemicals can change expression and function of metabolising enzymes.
  • Induction of enzymes and metabolism decreases drug effectiveness as it will be eliminated quicker and therefore will require an increased drug dose. (eg. CYP450 for paracetamol is enhanced by alcohol)
  • Inhibition increases the pharmacological effect of the drug and can lead to adverse effects. (alcohol can also inhibit metabolism)
40
Q

3 major processes of renal excretion (drug excretion)

A

1-Glomerular filtration: 20% of renal blood filtered through. Small molecules that are not bound to plasma proteins. [DEPENDS ON SIZE]
2-Tubular secretion: the 80% not filtered through glomerulus passes along capillaries. They are then transported into renal tubules via 2 carrier mediated active transport systems, 1 for transferring acids and the other for bases. Transport against a concentration gradient.
3-Tubular reabsorption: Water is reabsorbed into capillaries which changes concentration gradient. Passive diffusion of lipid soluble drugs into capillaries as they need to be metabolised more to become water soluble. Water soluble drugs stay in the tubules and go to collecting duct to be excreted. [DEPENDS ON LIPID SOLUBILITY, pKa, pH, IONISATION]

41
Q

Describe the 3 pharmacokinetic elimination parameters - What affects the plasma concentration of a drug.

A

1-Clearance (CL): measures ability of an organ to remove a drug from the body. Volume of plasma cleared per unit time. Affected by liver and kidney function.
2-Elimination rate constant (ke): rate at which elimination occurs. Exponential drop in concentration of drug as it is being metabolised. If conc of drug in body increases, then rate of elimination increases (first order kinetics)
3-Half life: time for conc of drug in the body to reduce by 50% of its initial value. Half life= log2 / ke

42
Q

How the pKa of drugs and pH of renal tubular fluid affects the excretion of drugs. How can we treat overdose of a weak base.

A
  • Ionisation and lipid solubility dependant on pKa of drug and pH of environment.
  • Changing pH of fluid can change excretion rates.
  • Drugs in a similar pH environment to them (acid drug in acidic conditions) are in an unionised state so are lipid soluble. Therefore they can be reabsorbed easily into the blood but less is excreted.
  • If fluid becomes more alkaline, then an acid drug becomes ionised and hydrophilic, so reabsorption diminishes & more is excreted.

-If a patient has overdosed a weak base, urinary acidification will accelerate excretion of bases and vice versa.

43
Q

What is an adverse drug reaction, side effects and secondary adverse effects

A

1-ADR is a seriously unpleasant and harmful event that occurs to someone after taking a dose intended for therapeutic effect. Usually unpredictable. It calls for a reduction in dose or withdrawal from it.
2-Side effects on the other hand are predictable unavoidable consequences of drug use that can be overcome and are not harmful. It arises because this unwanted action is just as integral as the therapeutic effect of the drug.
3-Secondary adverse reactions are indirect consequences of the drug’s prime reaction. For example immunosuppressant medication could cause opportunistic infections.

44
Q

What is the yellow card used for in drug safety. And what 4 features help us figure out if the drug is causing the adverse drug reaction

A
  • Prescribers or patients can report any suspected ADR associated with a drug they have taken. Data can then be collected to investigate any common links.
  • Features that suggest if the drug is causing the ADR: reasonable time sequence between taking drug and the reaction, the reaction corresponds to the known pharmacology of the drug, the reaction stops when withdrawn, the reaction returns if the drug is restarted.
45
Q

Risk factors of adverse drug reactions (how age, sex, lifestyle, ethnicity affects it)

A

1-old age: low glomerulus filtration and excretion rates so drug stays in body longer causing ADR. Also on more medications so potential for drug-drug interactions. And immunosuppressed so secondary reactions and weak immune response.
2-Young age: lower levels of some metabolising enzymes so cannot conjugate drugs as well.
3-Females: Lower growth factor affects P450 expression so lower metabolism
4-Medical history - If patient has had an ADR to a drug in the past, they may be more likely to experience an ADR to another drug
5-Ethnicity: genetics can cause differences in metabolism (Japanese have higher acetylation/ phase 1 metabolism)
6-Drug Interactions. Can inhibit or induce CYP450 which interferes with the metabolism of other drugs. Alcohol can interact with drugs.
7-Lifestyle: diet, smoking alcohol. Alcohol can inhibit or induce metabolism of drugs

46
Q

Explain the 5 categories of Adverse Drug Reactions. Give examples for each.
(ABCDE)

A
  • A: Augmented pharmacological effect: the expected response but more exaggerated than predicted. Common, low mortality and easily overcome. (treating bradycardia could cause very high HR)
  • B: Bizarre effects: unpredictable and unrelated to the pharmacology of the drug. Higher mortality, less common (eg. anaphylaxis by penicillin)
  • C: Chronic effects: occur as a result of taking prolonged treatment (glucocorticoid causing cushings syndrome)
  • D: Delayed effects: occur remote form the treatment, or it could occur in the child of the patient (Accutane causing birth defects)
  • E: End of treatment effects: occur as a result of stopping treatment
47
Q

target of sulphonamide antibacterials

A

folic acid synthesis

48
Q

What are the 4 main drug targets. What is the most common target for drugs

A
  • Receptors, ion channels, carrier molecules, enzymes

- Receptor most common

49
Q

What are ionotropic receptors

A
  • Receptors directly linked to channels.
  • Ligand-gated channels respond to ligands binding by opening an ion channel, causing depolarisation or polarisation /APs
50
Q

Give examples of excitatory and inhibitory neurotransmitters

A
  • Excitatory: acetylcholine, glutamate

- Inhibatory: GABA, glycine

51
Q

What are the 4 types of receptors, in increasing length of time action takes

A
  • Ligand-gated ion channels
  • G-protein coupled receptor
  • Enzyme linked receptor
  • Nuclear receptors
52
Q

What is a metabotropic receptor

A
  • G-protein coupled receptor

- membrane receptor that initiates a number of metabolic steps to modulate cell activity

53
Q

Is Gi or Gs protein coupled receptor excitatory

A

Gs is excitatory

Gi is inhibitory

54
Q

What does Bmax mean in terms of drug binding

A

-It is the binding potential of a receptor. The maximum number of binding sites

55
Q

Comment on the efficacy of antagonists

A
  • Efficacy of zero because there is no active state

- They do not cause any action

56
Q

Give an example of irreversible antagonism. Why it is not common

A
  • Phenoxybenzamine at a1 adrenoreceptor
  • Less common as we wouldn’t want to have complete inhibition of a normal signalling system that is important for physiological function
57
Q

What are catecholamine hormones and receptors

A
  • This class of hormones are made by adrenal glands. Dopamine, norepinephrine and adrenaline
  • The receptors are called adrenoreceptors. For example a1, B1 (in heart) and B2 (in lungs)
58
Q

What does a high and low half life of a drug mean

A
  • Very low half life means the concentration drops by 50% very quickly. Not ideal as would need to be administered very often
  • Very high means it can stay in the body for a long time and could be toxic
  • Ideal half life. Drug stays in the body for a fair amount of time
59
Q

Why is efficacy and potency important for drugs

A
  • Efficacy is important because we want the drug to have the desired effect and be effective
  • Potency is important because we don’t want to be administering too much of a drug as it could have toxic effects.
60
Q

Advantages and disadvantages of drug administration via IV and rectal

A
  • IV: Predictable, rapid, straight into circulation. No first-pass metabolism. BUT can be difficult, painful, expensive, infection risk & immediate adverse effects.
  • Vaginal/rectal: Bypasses GI/ Hepatic first pass effects. Rich blood supply so rapid absorption. Useful if patients vomitting. BUT can be inconsistent as absorption can vary between patients. Depends on drug & formulation too
61
Q

What is free-drug

A

-Free-drug is the amount of drug not bound in the plasma, and is distributed around the body tissues. It is pharmacologically active.

62
Q

What is a loading dose and why is it used.

A
  • It is an initial higher dose of a drug at the start of treatment, before dropping down to a lower maintenance dose
  • allows earlier achievement of effective concentration.
  • Useful for drugs with long half life that are eliminated slowly.
63
Q

Does lipophilic or hydrophilic drugs have high volume of distribution. will plasma concentration be high or low

A
  • Lipophilic. Cross membranes easily and they are stored in fatty tissue easily.
  • high vd =low plasma concentration, a lot goes into peripheral tissues
64
Q

How drugs are eliminated from the body

A
  • Metabolised and then excreted

- Excreted in kidneys, hepato-biliary system, lungs, sweating, milk.

65
Q

Where are CYP 450 enzymes found. What does the drug-CYP redox reaction require. What element of the enzyme allows a redox reaction to occur

A
  • mainly found in ER of hepatocytes of liver
  • Some in enterocytes of intestines. A few in kidneys, white blood cells and nasal passage.
  • Requires P450 reductase and NADPH.
  • Heme group allows redox reaction, as this allows it to gain a functional group.
  • different types are expressed in different sites & disease states
66
Q

What is involved in the conjugation reaction in metabolism. Reaction and enzymes

A
  • Glucuronidation where a glucronyl group is added to inactivate the drug and make it more water soluble
  • UDP-glucuronyl transferase enzyme mediates this system.
67
Q

What drug can inhibit aldehyde dehydrogenase, and its effects

A
  • Metronidazole antibiotic (for anaerobic infections)
  • Inhibits metabolism of alcohol so causes side effects
  • Causes nausea, vomitting, high heart rate
68
Q

What is the effect of alcohol on paracetamol

A
  • CYP450 enzyme is enhanced (phase 1 into a toxic metabolite)
  • so decreases drug effectiveness
69
Q

Are lipid soluble drugs excreted quickly or slowly

A
  • Highly lipid soluble drugs are highly permeable so enter into plasma and absorbed quickly. However, they need to be metabolised further to become more water soluble in order to be excreted. So lipid soluble drugs are slowly excreted.
  • Highly water soluble drugs have low permeability so stay in tubule to be excreted. They are excreted quickly.
70
Q

What factors affect the elimination half life of a drug

A
  • Clearance and the volume of distribution affects how quickly the drug can be eliminated from the plasma
  • Decreasing clearance rate and increasing volume of distribution will lengthen the half life.
71
Q

How glucocorticoids can develop Cushing Syndrome . What class of ADR is this

A
  • Glucocorticoids treat inflammatory diseases by increasing cortisol production.
  • Prolonged use can cause Cushing’s syndrome which is hypercortisolaemia.
  • Symptoms include buffalo hump on shoulders, easy bruising, round red face.
  • ADR= Chronic effect
72
Q

What is Addison’s disease. How can glucocorticoids cause it

A
  • Insufficient levels of cortisol and aldosterone made by the adrenal glands
  • Weakness, low mood, weight loss.
  • Prolonged use can cause adrenal atrophy, so once terminated the glands cannot produce enough hormones.
73
Q

How is cortisol produced.

A
  • Hyphothalamus releases CRH
  • Anterior pituitary releases ACTH
  • Adrenal cortex secretes cortisol
  • High cortisol causes negative feedback to switch the process off
  • Increases blood sugar and supresses the immune system
74
Q

Why might the half life of a drug be different in 2 different people

A

-Exercise, disease, drug-drug interactions (a drug may be a P450 inhibitor), age (slower metabolism and excretion), genetics

75
Q

The clinical importance of Clearance, Volume of distribution and half life

A
  • Vd: calculating the loading dose
  • CL: determining the maintenance dose
  • Half life: frequency of administration (- dose interval)
76
Q

Difference between bioavailability (F) and area under conc-time curve (AUC)

A
  • AUC is the total systemic exposure to a drug

- F is the proportion of administered drug that actually enters the systemic circulation

77
Q

What routes of administration bypass first pass metabolism

A

IV, topical, inhalation, rectal, sublingual

78
Q

Name 2 drugs that are excreted by zero order kinetics

A

Alcohol and aspirin